A Phase 3 interventional study of Measles, Mumps, Rubella and Chickenpox (live vaccine) in Measles, Rubella and Mumps, sponsored by GlaxoSmithKline. Completed at 48 sites in 3 countries. Open to participants aged 11 Months to 13 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-26.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Prevention
This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.
This study included an active control group who received the licensed Priorix (measles, mumps, rubella [MMR] vaccine).
134 studies on the registry are indexed under Measles; 17 are open to participants now.
Browse Measles studies →GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 118 are open to participants now.
Of its 264 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug page: Measles-Mumps-Rubella Vaccine
Also known as: Measles, Mumps, Rubella and Chickenpox (live vaccine)
Antibody levels after vaccination
Safety of the study vaccines
Plan to share: Yes — Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.
This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Measles-Mumps-Rubella Vaccine